What is Ascertain?
Ascertain is a specialized entity formed by Northwell Health and Aegis Ventures, dedicated to the efficient creation and deployment of healthcare artificial intelligence companies. The firm provides advanced automation technology and AI agents designed to optimize the operational workflows of health systems, payors, and pharmacies. Founded by a team with deep expertise from tech giants like Amazon, Microsoft, and Google, Ascertain leverages cutting-edge AI to enhance healthcare system efficiency and improve patient care pathways. Their core offering includes AI agents that automate repetitive administrative and clinical tasks within the healthcare sector.
How much funding has Ascertain raised?
Ascertain has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2025): $10M with participation from Deerfield and Northwell Health
Key Investors in Ascertain
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy, supporting companies across the healthcare ecosystem with flexible funding models and driving innovation using AI, data, and market research.
Northwell Health
Northwell Health is New York's largest healthcare provider, operating hospitals and outpatient facilities, committed to delivering high-quality patient care, advancing medical research, and training healthcare professionals.
What's next for Ascertain?
With its recent major strategic investment and a clear focus on enterprise-level funding, Ascertain is poised for accelerated growth and market expansion. The company's strategy likely involves scaling its AI agent deployment across a broader range of healthcare organizations, further enhancing operational efficiencies and patient outcomes. Future developments may include the introduction of new AI-driven solutions tailored to emerging challenges in the healthcare industry, solidifying its position as a leader in healthcare AI innovation. The backing from established healthcare and investment entities suggests a trajectory towards significant impact and market penetration.
See full Ascertain company page
